학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 32건 | 목록 1~10
Academic Journal
Scott M; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; BlueRock Therapeutics, Toronto, Canada.; Clarke D; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; HemaCare Corporation, Northridge, California, USA.; Lipsitz Y; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Sana Biotechnology, Cambridge, Massachusetts, USA.; Brandwein H; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Cook Myosite, Indianapolis, Indiana, USA.; Allickson J; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.; Alzebdeh D; Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.; Aleksic S; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; Fujifilm Irvine Scientific, Irvine, California, USA.; Kraft C; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; West Pharmaceuticals, Exton, Pennsylvania, USA.; Lhu L; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, Canada; PBS Biotech, Camarillo, California, USA.; Cornetta K; Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Academic Journal
Campbell A; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore andrew.campbell@thermofisher.com.; Brieva T; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Raviv L; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Rowley J; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Niss K; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Brandwein H; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Oh S; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.; Karnieli O; International Society for Cellular Therapy Process and Product Development Subcommittee, Vancouver, British Columbia, Canada; Thermo Fisher Scientific, Inc., Grand Island, New York, USA; Celgene Cellular Therapeutics, Warren, New Jersey, USA; Pluristem Therapeutics Inc., Haifa, Israel; Rooster Bio Inc., Frederick, Maryland, USA; Novartis Pharmaceuticals, Morris Plains, New Jersey, USA; Pall Life Sciences (division of Pall Corp), Port Washington, New York, USA; Stem Cell Group, Bioprocessing Technology Institute, ASTAR, Singapore, Singapore.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101578022 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2157-6564 (Print) Linking ISSN: 21576564 NLM ISO Abbreviation: Stem Cells Transl Med Subsets: MEDLINE
Academic Journal
Eaker S; International Society for Cellular Therapy.; Armant MBrandwein HBurger SCampbell ACarpenito CClarke DFong TKarnieli ONiss KVan't Hof WWagey R
Publisher: Oxford University Press Country of Publication: England NLM ID: 101578022 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2157-6564 (Print) Linking ISSN: 21576564 NLM ISO Abbreviation: Stem Cells Transl Med Subsets: MEDLINE
Academic Journal
Czystowska M; Research Pavilion at Hillman Cancer Center, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Suite 1.27, Pittsburgh, PA 15213-1863, USA.; Szczepanski MJSzajnik MQuadrini KBrandwein HHadden JWWhiteside TL
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Academic Journal
Czystowska M; University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.; Han JSzczepanski MJSzajnik MQuadrini KBrandwein HHadden JWSignorelli KWhiteside TL
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE
Academic Journal
Sundaram S; Pall Corporation, Scientific and Laboratory Services Department, Port Washington, NY, USA. Sri_Sundaram@pall.com; Eisenhuth JSteves MHoward G JrBrandwein H
Publisher: Pda (Parenteral Drug Association) Country of Publication: United States NLM ID: 9439538 Publication Model: Print Cited Medium: Print ISSN: 1079-7440 (Print) Linking ISSN: 10797440 NLM ISO Abbreviation: PDA J Pharm Sci Technol Subsets: MEDLINE
Academic Journal
Sundaram S; Pall Corporation, Scientific and Laboratory Services Department, Port Washington, NY, USA. Sri_Sundaram@pall.com; Eisenhuth JHoward G JrBrandwein H
Publisher: Pda (Parenteral Drug Association) Country of Publication: United States NLM ID: 9439538 Publication Model: Print Cited Medium: Print ISSN: 1079-7440 (Print) Linking ISSN: 10797440 NLM ISO Abbreviation: PDA J Pharm Sci Technol Subsets: MEDLINE
Academic Journal
Sundaram S; Pall Corporation, Scientific and Laboratory Services Department, Port Washington, NY, USA. Sri_Sundaram@pall.com; Eisenhuth JLewis MHoward G JrBrandwein H
Publisher: Pda (Parenteral Drug Association) Country of Publication: United States NLM ID: 9439538 Publication Model: Print Cited Medium: Print ISSN: 1079-7440 (Print) Linking ISSN: 10797440 NLM ISO Abbreviation: PDA J Pharm Sci Technol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Brandwein H
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어